ASCP 2023 - Day 2 - Scientific Keynote Address - Dr. Kizzmekia Corbett-Helaire

Dr. Kizzmekia Corbett-Helaire was the scientific lead of the Vaccine Research Center’s coronavirus team at the U.S. National Institutes of Health where she studied coronavirus biology and vaccine development. Those 6 years of research led to the groundbreaking discovery that a stabilized version of a spike protein, which is found on the surface of all coronaviruses, would be a key target for vaccines, treatments, and diagnostics.
At the onset of the COVID-19 pandemic, she and her colleagues were central to the development of the Moderna mRNA vaccine and the Eli Lilly therapeutic monoclonal antibody, both of which were first to enter clinical trials in the world. As a result, her work is having a substantial impact on ending the worst respiratory-disease pandemic in more than 100 years. Dr. Corbett-Helaire is now an assistant professor in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health. Her work now extends beyond the rapid development of COVID-19 vaccines to the outlook of this pandemic and future viral pandemics.